Skip to main content
. 2022 Apr 28;11(9):2488. doi: 10.3390/jcm11092488

Table 4.

Assessed electrocardiogram parameters.

Characteristic Total (n = 77) Control (n = 38) MAFLD (n = 39) p-Value
ECG—rhythm: 0.52
Normal Sinus Rhythm, n (%) 65 (84.42) 34 (89.47) 31 (79.49)
Tachycardia, n (%) 2 (2.6) 1 (2.63) 1 (2.56)
Bradycardia, n (%) 10 (12.99) 3 (7.89) 7 (17.95)
Heart rate (bpm), median (IQR) 71 (66–77) 70.5 (66–75.5) 71 (64–78) 0.787
RR interval (ms), median (IQR) 850 (782–920) 856.5 (834–922.75) 845 (761.5–918) 0.287
QRS (ms), median (IQR) 92 (86–98) 91 (86.5–95.75) 92 (86–102) 0.275
P (ms), median (IQR) 108 (100–120) 105 (98.5–113.5) 118 (102–124) 0.002
PR interval (ms), median (IQR) 156 (140–170) 149.5 (134.5–160) 161 (144–180) 0.008
QT interval (ms), median (IQR) 382 (370–398) 382 (374.5–395.5) 380 (369–400) 0.967
QTc interval (Bazett’s formula) (ms), median (IQR) 413.12 (403.33–429.76) 412.17 (402.74–423.71) 421 (405.4–439.52) 0.064
measured JT (JTm) (ms), median (IQR) 290 (280–314) 290.5 (282.5–312.5) 290 (276–311) 0.83
corrected JT (JTc) (ms), mean (SD) 324.58 (26.49) 321.11 (24.93) 327.97 (27.82) 0.258

IQR—Interquartile range; MAFLD—Metabolic-associated fatty liver disease.